Akut mieloid leukémia (AML): vizsgálatok itt: Ausztrália
22 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
- Where
- Heidelberg, Kurralta Park, Melbourne, Murdoch, South Brisbane, Waratah
- Életkor
- 18 év and over
- People
- 1300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT07007312 · EU 2025-521314-25-00 - 3. fázisTaking peopleBleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
- Where
- Adelaide, Birtinya, Brisbane, Camperdown, Melbourne, Sydney
- Életkor
- 18 év and over
- People
- 875 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07223814 · EU 2025-522767-15-00 - 1. fázisCsak meghívásosA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Macquarie University, Melbourne, Nedlands, Randwick
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 3. fázisTaking peopleA Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
- Where
- Bedford Park, Camperdown, Fitzroy, Kogarah, Melbourne, Woolloongabba
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06852222 · EU 2024-520154-38-00 - 1. fázisTaking peopleA Study to Investigate APL-4098 Alone and in Combination in Adults With AML or MDS
- Where
- Clayton, Fitzroy, Melbourne, Nedlands, Perth
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Apollo Therapeutics Ltd
See details and how to joinNCT06372717 - 1/2. fázisFelfüggesztveStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Fitzroy, Perth
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 3. fázisTaking peopleStudy of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
- Where
- Douglas, Gosford, Kingswood, Kogarah, Melbourne, Nedlands, Parkville, Perth, Randwick, South Brisbane, Wollongong
- Életkor
- 12 év and over
- People
- 468 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Melbourne, Nedlands, Parkville, Saint Leonards
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1. fázisTaking peopleA Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Perth, Westmead
- Életkor
- 6 hónap to 17 év
- People
- 18 worldwide
- Run by
- AbbVie
See details and how to joinNCT07306832 - 3. fázisFut, nem toborozA Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- Where
- Perth, Randwick, South Brisbane, Westmead
- Életkor
- 6 hónap to 21 év
- People
- 1400 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT04293562 - 2. fázisTaking peopleEvaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
- Where
- Adelaide, Australia, Darlinghurst, Melbourne, Perth, Southport, Sydney
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06824168 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Kingswood, Melbourne N., Southport
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 1/2. fázisTaking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Clayton, Concord, Fitzroy, Heidelberg, Kogarah, Melbourne, Murdoch, Nedlands, Orange, Southport
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - 3. fázisTaking peopleRevumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
- Where
- Adelaide, Birtinya, Brisbane, Douglas, Melbourne, Perth, Sydney
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06652438 · EU 2024-512733-32-00 - 1/2. fázisTaking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Parkville, Perth, South Brisbane, Westmead
- Életkor
- Up to 22 év
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - 1. fázisTaking peopleICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Where
- Perth, Sydney
- Életkor
- 18 év and over
- People
- 266 worldwide
- Run by
- Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06656494 - 1/2. fázisTaking peopleStudy to Evaluate the Safety and Tolerability of EP0042
- Where
- Perth
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Ellipses Pharma
See details and how to joinNCT04581512 · EU 2024-514588-24-00 - 1. fázisTaking peopleCombined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
- Where
- Sydney, Westmead
- Életkor
- 18 év and over
- People
- 12
- Run by
- Clinical Hub for Interventional Research (CHOIR)
See details and how to joinNCT05636514 - 1. fázisTaking peopleDose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Melbourne, Perth
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- Lomond Therapeutics Holdings, Inc.
See details and how to joinNCT06366789 - No phaseTaking peopleEvaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX
- Where
- Canberra, Sydney, Westmead
- Életkor
- 18 év and over
- People
- 25
- Run by
- Clinical Hub for Interventional Research (CHOIR)
See details and how to joinNCT06782971 - 1/2. fázisFut, nem toborozClinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Albury, Fitzroy, Herston, Nedlands, Townsville
- Életkor
- 18 év and over
- People
- 240 worldwide
- Run by
- Aptose Biosciences Inc.
See details and how to joinNCT03850574 · EU 2023-503244-14-00 - 1. fázisTaking peopleA Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients With Advanced Cancer
- Where
- Clayton
- Életkor
- 18 év and over
- People
- 32 worldwide
- Run by
- PharmaEngine
See details and how to joinNCT05659732